Clinical Trial Update: A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase II trial evaluating Genexol-PM in combination with Gemcitabine for advanced non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Genexol-PM (paclitaxel)

Snippet

Sponsor: Gachon University Gil Medical Center | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED